Capital World Investors 13D/13G Filings for Flexion Therapeutics, Inc. (FLXN)

Capital World Investors 13D and 13G filings for Flexion Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
12:45 pm
Purchase
2021-02-16 13G Flexion Therapeutics, Inc.
FLXN
Capital World Investors 3,823,000
7.800%
1,312,300increase
(+52.27%)
Filing